| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |